207 related articles for article (PubMed ID: 23607197)
1. [Fundamental approaches to the treatment of refractory and relapsed Hodgkin lymphoma].
Filatova LV; Tarasenkova AA; Semiglazova TIu; Gershanovich ML
Vopr Onkol; 2012; 58(4):443-53. PubMed ID: 23607197
[No Abstract] [Full Text] [Related]
2. Salvage therapy in Hodgkin's lymphoma.
Mendler JH; Friedberg JW
Oncologist; 2009 Apr; 14(4):425-32. PubMed ID: 19342476
[TBL] [Abstract][Full Text] [Related]
3. Stem cell transplantation in Hodgkin lymphoma.
Murphy F; Sirohi B; Cunningham D
Expert Rev Anticancer Ther; 2007 Mar; 7(3):297-306. PubMed ID: 17338650
[TBL] [Abstract][Full Text] [Related]
4. Management of relapsed and refractory classical Hodgkin lymphoma in children and adolescents.
Daw S; Wynn R; Wallace H
Br J Haematol; 2011 Feb; 152(3):249-60. PubMed ID: 21133886
[TBL] [Abstract][Full Text] [Related]
5. Autologous and allogeneic stem cell transplantation in Hodgkin's lymphoma.
Sureda A
Hematol Oncol Clin North Am; 2007 Oct; 21(5):943-60. PubMed ID: 17908630
[TBL] [Abstract][Full Text] [Related]
6. Tumor associated macrophages in relapsed and refractory Hodgkin lymphoma.
Casulo C; Arcila M; Bohn OL; Teruya-Feldstein J; Maragulia J; Moskowitz CH
Leuk Res; 2013 Sep; 37(9):1178-83. PubMed ID: 23706570
[TBL] [Abstract][Full Text] [Related]
7. Relapsed/refractory Hodgkin lymphoma: what is the best salvage therapy and do we need RIC-alloSCT?
Hertzberg M
Hematol Oncol Clin North Am; 2014 Feb; 28(1):123-47. PubMed ID: 24287072
[TBL] [Abstract][Full Text] [Related]
8. Mini-BEAM is effective as a bridge to transplantation in patients with refractory or relapsed Hodgkin lymphoma who have failed to respond to previous lines of salvage chemotherapy but not in patients with salvage-refractory DLBCL.
Moore S; Kayani I; Peggs K; Qian W; Lowry L; Thomson K; Linch DC; Ardeshna K
Br J Haematol; 2012 Jun; 157(5):543-52. PubMed ID: 22429186
[TBL] [Abstract][Full Text] [Related]
9. Ifosfamide, idarubicin, and etoposide in relapsed/refractory Hodgkin disease or non-Hodgkin lymphoma: a salvage regimen with high response rates before autologous stem cell transplantation.
Oyan B; Koc Y; Ozdemir E; Kars A; Turker A; Tekuzman G; Kansu E
Biol Blood Marrow Transplant; 2005 Sep; 11(9):688-97. PubMed ID: 16125639
[TBL] [Abstract][Full Text] [Related]
10. [Therapy for patients with primary refractory and relapsed Hodgkin-lymphoma--our experience].
Miltényi Z; Simon Z; Páyer E; Váróczy L; Gergely L; Illés A
Orv Hetil; 2010 Jan; 151(5):172-8. PubMed ID: 20083465
[TBL] [Abstract][Full Text] [Related]
11. Salvage chemotherapy with mini-BEAM for relapsed or refractory Hodgkin's disease prior to autologous peripheral blood stem cell transplantation.
Fernández-Jiménez MC; Canales MA; Ojeda E; de Bustos JG; Aguado MJ; Hernández-Navarro F
Haematologica; 1999 Nov; 84(11):1007-11. PubMed ID: 10553161
[TBL] [Abstract][Full Text] [Related]
12. Stem cell transplantation in Hodgkin lymphoma.
Reddy NM; Perales MA
Hematol Oncol Clin North Am; 2014 Dec; 28(6):1097-112. PubMed ID: 25459181
[TBL] [Abstract][Full Text] [Related]
13. Conventional second-line salvage chemotherapy regimens are not warranted in patients with malignant lymphomas who have progressive disease after first-line salvage therapy regimens.
Ardeshna KM; Kakouros N; Qian W; Powell MG; Saini N; D'Sa S; Mackinnon S; Hoskin PJ; Goldstone AH; Linch DC
Br J Haematol; 2005 Aug; 130(3):363-72. PubMed ID: 16042685
[TBL] [Abstract][Full Text] [Related]
14. The role of hematopoietic stem cell transplantation in Hodgkin lymphoma.
Moskowitz C; Sweetenham J
Cancer Treat Res; 2009; 144():399-414. PubMed ID: 19779881
[No Abstract] [Full Text] [Related]
15. Relapsed and refractory Hodgkin lymphoma: transplantation strategies and novel therapeutic options.
David KA; Mauro L; Evens AM
Curr Treat Options Oncol; 2007 Oct; 8(5):352-74. PubMed ID: 18214690
[TBL] [Abstract][Full Text] [Related]
16. Consolidation therapy after autologous stem cell transplant in relapsed/refractory Hodgkin lymphoma.
Moskowitz CH
Clin Adv Hematol Oncol; 2016 Sep; 14(9):662-4. PubMed ID: 27673283
[No Abstract] [Full Text] [Related]
17. Intensive conditioning regimen of etoposide (VP-16), cyclophosphamide and carmustine (VCB) followed by autologous hematopoietic stem cell transplantation for relapsed and refractory Hodgkin's lymphoma.
Benekli M; Smiley SL; Younis T; Czuczman MS; Hernandez-Ilizaliturri F; Bambach B; Battiwalla M; Padmanabhan S; McCarthy PL; Hahn T
Bone Marrow Transplant; 2008 Apr; 41(7):613-9. PubMed ID: 18071290
[TBL] [Abstract][Full Text] [Related]
18. Comparison of ICE (ifosfamide-carboplatin-etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma.
Abali H; Urün Y; Oksüzoğlu B; Budakoğlu B; Yildirim N; Güler T; Ozet G; Zengin N
Cancer Invest; 2008 May; 26(4):401-6. PubMed ID: 18443961
[TBL] [Abstract][Full Text] [Related]
19. Intensive therapy and autotransplantation in Hodgkin's disease.
Reece DE; Phillips GL
Stem Cells; 1994 Sep; 12(5):477-93. PubMed ID: 7804123
[TBL] [Abstract][Full Text] [Related]
20. Bendamustine can be a bridge to allogeneic transplantation in relapsed Hodgkin lymphoma refractory to brentuximab vedotin.
Howell M; Gibb A; Radford J; Linton K
Br J Haematol; 2017 Dec; 179(5):841-843. PubMed ID: 27447404
[No Abstract] [Full Text] [Related]
[Next] [New Search]